Amit Hasija - CFO & EVP of Corp. Development at Milestone Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CFO & EVP of Corp. Development
Issuer Symbol
MIST on Nasdaq
All Insider Reports
All Insider Reports

Amit Hasija - trading volume in the past year for Milestone Pharmaceuticals Inc.

Holdings reported by Amit Hasija for Milestone Pharmaceuticals Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 99,848 $192,706 $1.93 26 Jan 2026 Direct
Employee Stock Option (right to buy) 204,000 02 Feb 2026 Direct Common Shares
Restricted Stock Unit 136,000 02 Feb 2026 Direct Common Shares
Restricted Stock Units 60,300 26 Jan 2026 Direct Common Shares
Series A Common Warrants (right to buy) 50,000 11 Jul 2025 Direct Common Shares
Series B Common Warrants (right to buy) 50,000 11 Jul 2025 Direct Common Shares

Transactions reported by Amit Hasija for Milestone Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.